Kathryn Loydall, PhD
Articles by Kathryn Loydall, PhD
Fragile mRNA molecules depend on protective carriers to transport them into cells.
| 1 min read
| 1 min read
The history of antibody research has led to modern immunotherapy treatments for infectious diseases.
| 1 min read
The recent COVID-19 mRNA vaccines represent a new wave of vaccines based on mRNA technology.
Methods for identifying single nucleotide polymorphisms reveal insights into disease pathogenesis, disease susceptibility, and drug response.
| 6 min read
From excising integrated viral sequences to modifying stem cells, CRISPR offers new possibilities for developing HIV treatments.
| 5 min read
Bacteria engineered to produce therapeutics fill a niche for patients with unmet medical needs.
Page 1 of 1 - 7 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
The crucial role of sample preparation in biotherapy manufacturing
Discover how better sample preparation can unlock improved assay accuracy and analytical results.
Discovering deeper insights into malaria research
Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Accelerating RNA therapeutic testing with liver microphysiological platforms
Researchers can now study oligonucleotide delivery and efficacy in a system that models a real human liver.
